PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 79 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 44.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $52,633,000 | -27.6% | 13,850,498 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $72,730,000 | +4.9% | 14,288,924 | +4.1% | 0.00% | 0.0% |
| Q3 2019 | $69,360,000 | -18.2% | 13,720,955 | -0.2% | 0.00% | -25.0% |
| Q2 2019 | $84,792,000 | +35.0% | 13,742,674 | +1.5% | 0.00% | +33.3% |
| Q1 2019 | $62,793,000 | +10.5% | 13,532,987 | +0.0% | 0.00% | 0.0% |
| Q4 2018 | $56,828,000 | -31.8% | 13,530,763 | +1.8% | 0.00% | -25.0% |
| Q3 2018 | $83,349,000 | -9.0% | 13,293,243 | +16.7% | 0.00% | 0.0% |
| Q2 2018 | $91,584,000 | +22.9% | 11,391,237 | +14.0% | 0.00% | 0.0% |
| Q1 2018 | $74,522,000 | +25.3% | 9,989,673 | -0.1% | 0.00% | +33.3% |
| Q4 2017 | $59,482,000 | -17.5% | 9,996,741 | +2.1% | 0.00% | -25.0% |
| Q3 2017 | $72,082,000 | +10.7% | 9,793,809 | +2.1% | 0.00% | +33.3% |
| Q2 2017 | $65,114,000 | -27.6% | 9,589,820 | +0.7% | 0.00% | -40.0% |
| Q1 2017 | $89,897,000 | +163349.1% | 9,523,053 | +149468.9% | 0.01% | – |
| Q4 2016 | $55,000 | +31.0% | 6,367 | -3.6% | 0.00% | – |
| Q3 2016 | $42,000 | +75.0% | 6,603 | +12.4% | 0.00% | – |
| Q2 2016 | $24,000 | +26.3% | 5,875 | +40.6% | 0.00% | – |
| Q1 2016 | $19,000 | +111.1% | 4,179 | +173.3% | 0.00% | – |
| Q4 2015 | $9,000 | 0.0% | 1,529 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | -18.2% | 1,529 | 0.0% | 0.00% | – |
| Q2 2015 | $11,000 | 0.0% | 1,529 | -20.3% | 0.00% | – |
| Q1 2015 | $11,000 | -26.7% | 1,918 | 0.0% | 0.00% | – |
| Q4 2014 | $15,000 | +50.0% | 1,918 | 0.0% | 0.00% | – |
| Q3 2014 | $10,000 | +25.0% | 1,918 | 0.0% | 0.00% | – |
| Q2 2014 | $8,000 | 0.0% | 1,918 | -3.2% | 0.00% | – |
| Q1 2014 | $8,000 | 0.0% | 1,981 | +32.3% | 0.00% | – |
| Q4 2013 | $8,000 | 0.0% | 1,497 | 0.0% | 0.00% | – |
| Q3 2013 | $8,000 | +14.3% | 1,497 | 0.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 1,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|